Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Ortikos vs. Entyvio

Are Ortikos and Entyvio the Same Thing?

Ortikos (budesonide) and Entyvio (vedolizumab) are used to treat active Crohn's disease.

Ortikos is used to treat mild to moderate active Crohn's disease involving the ileum and/or the ascending colon, in patients 8 years and older; and for maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months in adults.

Entyvio is used to treat moderate to severe active Crohn's disease (CD) and also to treat moderate to severe active ulcerative colitis (UC).

Ortikos and Entyvio belong to different drug classes. Ortikos is a corticosteroid and Entyvio is an IgG1 monoclonal antibody.

Side effects of Ortikos and Entyvio that are similar include headache, respiratory infection, nausea, back pain, and fatigue.

Side effects of Ortikos that are different from Entyvio include indigestion/heartburn, dizziness, abdominal pain, gas (flatulence), vomiting, and pain.

Side effects of Entyvio that are different from Ortikos include common cold symptoms (runny or stuffy nose, sinus pain, sneezing, cough), joint pain, fever, infections of the nose and throat, tiredness, bronchitis, flu symptoms, rash, itching, sinus infection, sore throat, and pain in your arms or legs.

Ortikos may interact with CYP3A4 Inhibitors (e.g., ketoconazole, grapefruit juice, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, and cyclosporine).

Entyvio may interact with natalizumab, TNF blockers, and "live" vaccines.

What Are Possible Side Effects of Ortikos?

Common side effects of Ortikos include:

  • headache,
  • respiratory infection,
  • nausea,
  • back pain,
  • indigestion/heartburn,
  • dizziness,
  • abdominal pain,
  • gas (flatulence),
  • vomiting,
  • fatigue, and
  • pain

What Are Possible Side Effects of Entyvio?

Common side effects of Entyvio include:

  • common cold symptoms (runny or stuffy nose, sinus pain, sneezing, cough),
  • headache,
  • joint pain,
  • nausea,
  • fever,
  • infections of the nose and throat,
  • tiredness,
  • fatigue,
  • upper respiratory tract infection,
  • bronchitis,
  • flu symptoms,
  • back pain,
  • rash,
  • itching,
  • sinus infection,
  • sore throat, and
  • pain in your arms or legs.

What Is Ortikos?

Ortikos (budesonide) is a corticosteroid indicated for treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon, in patients 8 years and older; and maintenance of clinical remission of mild to moderate Crohn' disease involving the ileum and/or the ascending colon for up to 3 months in adults.

What Is Entyvio?

Entyvio (vedolizumab) is an IgG1 monoclonal antibody used to treat moderate to severe active ulcerative colitis (UC) and moderate to severe active Crohn's disease (CD).

SLIDESHOW

Inflammatory Bowel Disease (IBD) Causes, Symptoms, Treatment See Slideshow

What Drugs Interact With Ortikos?

Ortikos may interact with CYP3A4 Inhibitors (e.g., ketoconazole, grapefruit juice, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, and cyclosporine). Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Ortikos; it may harm a fetus.

What Drugs Interact With Entyvio?

Entyvio may interact with natalizumab, TNF blockers, and "live" vaccines. Tell your doctor all medications and supplements you use and all vaccines you recently received. Tell your doctor if you are pregnant or plan to become pregnant before using Entyvio. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

How Should Ortikos Be Taken?

The recommended adult dosage of Ortikos for mild to moderate active Crohn's disease is 9 mg once daily for up to 8 weeks; repeat 8-week treatment courses recurring episodes of active disease. The recommended dosage of Ortikos for pediatric patients 8 to 17 years who weigh more than 25 kg is 9 mg once daily for up to 8 weeks, followed by 6 mg once daily in the morning for 2 weeks.

How Should Entyvio Be Taken?

The recommended dosage of Entyvio in adults with ulcerative colitis or Crohn's disease is 300 mg administered by intravenous infusion at zero, two, and six weeks, and then every eight weeks thereafter.

QUESTION

What is Crohn's disease? See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

Reviewed on 9/26/2019
References

FDA. Ortikos Drug Information.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211929s000lbl.pdf

Takeda. Entyvio Drug Information.

https://www.entyvio.com
CONTINUE SCROLLING FOR RELATED SLIDESHOW

Health Solutions From Our Sponsors